Ocubio

Ocubio is a medical technology company focused on revolutionizing the treatment of chronic retinal diseases through advanced drug delivery systems. The company's core technology is an implantable, refillable micro-pump based on micro-electromechanical systems (MEMS) designed to provide sustained release of therapeutics directly into the eye. This approach aims to replace the current standard of care, which requires frequent and burdensome intravitreal injections. Ocubio's lead applications target major blinding diseases, including age-related macular degeneration and diabetic retinopathy. By ensuring consistent therapeutic levels, the company seeks to improve long-term visual outcomes and patient adherence.